{
    "clinical_study": {
        "@rank": "85621", 
        "arm_group": {
            "arm_group_label": "M2 macrophages", 
            "arm_group_type": "Other", 
            "description": "M2 macrophage introduction"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether M2 macrophages are safe and feasible in\n      the treatment of non-acute stroke patients"
        }, 
        "brief_title": "Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ischemic Stroke", 
            "Hemorrhagic Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Stroke", 
                "Cerebral Infarction", 
                "Intracranial Hemorrhages"
            ]
        }, 
        "detailed_description": {
            "textblock": "Our primary hypothesis is that autologous M2 macrophage transplantation via intrathecal\n      introduction is feasible and safe after non-acute stroke. Our secondary hypothesis is that\n      autologous M2 macrophage transplantation is associated with improved neurological outcome\n      after non-acute stroke"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Computed tomography confirmed ischemic or hemorrhagic stroke\n\n          -  Duration since stroke onset more than 3 and less than 12 months\n\n          -  Age between 18 and 75 years old\n\n          -  Persistent neurological deficits more than 4 points in NIHSS stroke scale\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  The history of previous stroke\n\n          -  Seizures\n\n          -  Thrombophilias or primary hematological diseases\n\n          -  Malignancy\n\n          -  Hepatic or renal dysfunctions\n\n          -  Hemodynamic or respiratory instability\n\n          -  Autoimmune disease\n\n          -  HIV or uncontrolled bacterial, fungal, or viral infections\n\n          -  Pregnancy\n\n          -  Participation in other clinical trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01845350", 
            "org_study_id": "STR-M2-2013"
        }, 
        "intervention": {
            "arm_group_label": "M2 macrophages", 
            "description": "Generation of autologous M2 macrophages from peripheral blood of non-acute stroke patients\nIntrathecal introduction of autologous M2 macrophages", 
            "intervention_name": "M2 macrophage introduction", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 29, 2013", 
        "location": {
            "contact": {
                "email": "ct_lab@mail.ru", 
                "last_name": "Elena R Chernykh, MD, PhD", 
                "phone": "+7(383)236-03-29"
            }, 
            "contact_backup": {
                "email": "shevelak@mail.ru", 
                "last_name": "Ekaterina Y Shevela, MD", 
                "phone": "+7(383)236-03-29"
            }, 
            "facility": {
                "address": {
                    "city": "Novosibirsk", 
                    "country": "Russian Federation", 
                    "zip": "630099"
                }, 
                "name": "Research Institute of Clinical Immunology, Russian Academy of Medical Sciences (Siberian Branch)"
            }, 
            "investigator": [
                {
                    "last_name": "Mariya N Davydova", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ekaterina Y Shevela, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "1", 
        "official_title": "Safety and Feasibility of Autologous M2 Macrophage Transplantation in Treatment of Non-Acute Stroke Patients", 
        "other_outcome": {
            "measure": "Number of patients with recurrent vascular episodes", 
            "safety_issue": "Yes", 
            "time_frame": "1-3 days, 6 months"
        }, 
        "overall_contact": {
            "email": "starostina48@bk.ru", 
            "last_name": "Nataliya M Starostina, MD", 
            "phone": "+7(383)228-27-41"
        }, 
        "overall_contact_backup": {
            "email": "shevelak@mail.ru", 
            "last_name": "Ekaterina Y Shevela, MD", 
            "phone": "+7(383)236-03-29"
        }, 
        "overall_official": {
            "affiliation": "Research Institute of Clinical Immunology, Russian Academy of Medical Sciences (Siberian Branch)", 
            "last_name": "Elena R. Chernykh, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Occurence of severe adverse events including mortality, neurological worsening and seizures", 
            "measure": "The number of patients with severe adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1-3 days, 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01845350"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Siberian Branch of the Russian Academy of Medical Sciences", 
            "investigator_full_name": "Ekaterina Y. Shevela", 
            "investigator_title": "Senior Researcher, Laboratory of Cellular Therapy, Research Institute of Clinical Immunology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement of functional outcome in National Institutes of Health Stroke Scale (NIHSS)", 
                "safety_issue": "No", 
                "time_frame": "1-3 days, 6 months"
            }, 
            {
                "measure": "Improvement in Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "1-3 days, 6 months"
            }, 
            {
                "measure": "Improvement in modified Rankin scale", 
                "safety_issue": "No", 
                "time_frame": "1-3 days, 6 months"
            }
        ], 
        "source": "Siberian Branch of the Russian Academy of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Siberian Branch of the Russian Academy of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}